Get the latest Science News and Discoveries
SGLT2 inhibitor empagliflozin is shown to be safe and effective for treating patients who have suffered a heart attack - EurekAlert
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
None
Or read this on Eureka Alert